Docklands growth dominates strategy

By James Whitmore, Clayton Hirst, James Whitmore Clayton Hirst5 March 1999

The prospect of a huge £6bn property company dominating the central London office market would be mouth-watering for investors, who are starved of a property equivalent to BP Amoco or GlaxoWellcome.

This content is only available to registered users

You must be logged in to continue

Would you like to read more?

Register for free to finish this article.

Four FREE articles of your choice per month
Breaking news, comment and analysis from industry experts as it happens
Choose from our portfolio of email newsletters

To access this article REGISTER NOW

Would you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week.

Registered users and subscribers SIGN IN here to continue